# Ivermectina Colombia (IVERCOL)

> **NCT04886362** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ayudas Diagnosticas Sura S.A.S** · enrollment: 966 (estimated)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04886362
- **Lead sponsor:** Ayudas Diagnosticas Sura S.A.S
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 966 (ESTIMATED)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04886362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04886362, "Ivermectina Colombia (IVERCOL)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04886362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*